Inavolisib plus palbociclib-fulvestrant yields significantly longer progression-free survival than placebo plus palbociclib-fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, ...

Under this two-hit model, Brugge says, one normal copy of BRCA1 ought to be able to carry out DNA repair even when the other ...

A Michigan State University researcher's new model for studying breast cancer could help scientists better understand why and ...

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.

Reported interim RLY-2608 data demonstrating 9.2-month median PFS in heavily pre-treated patients with PI3Kα-mutated, HR+/HER2- metastatic breast ...

TD Cowen analyst Tyler Van Buren has reiterated their bullish stance on ARVN stock, giving a Buy rating on October 22. Tyler Van Buren’s ...

Among the many impactful sessions, a symposium titled ‘Incorporating Novel Treatment Insights for Estrogen Receptor-Positive (ER+) Early Breast Cancer Patients’ garnered particular attention.

before cancer has spread outside of the breast, when it is easiest to treat. The 5-year relative survival rate for cancer diagnosed at the localized stage is 99%. Approximately 15% of women ...

One in every eight women will be diagnosed with breast cancer. Survival rates are higher if it is caught early. The money raised by the walk will support a number of programs, including making ...

Breast cancer accounts for nearly one-third of all new cancer diagnoses in Israeli women each year. One key reason behind the high rates of breast cancer is ... as symbols of strength and survival.

Basel: This month, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for breast cancer were updated to recommend ribociclib (Kisqali ... demonstrated statistically significant ...

suggests breast self-exams don't have a meaningful effect on breast cancer survival rates and groups like the Canadian Task Force on Preventive Health Care actively recommend against telling women ...